The China Mail - Boulevard

UN says Israel bombardment of Syria 'must stop'

The UN special envoy for Syria called Tuesday on Israel to halt its military movements and bombardments in Syria, after a war monitor reported 300 air strikes since the fall of president Bashar al-Assad.

Award-winning US poet Nikki Giovanni dies aged 81

Award-winning US poet Nikki Giovanni, who was at the forefront of the Black Arts Movement, died aged 81 after a long battle with cancer, local media reported Tuesday.

Israel's PM Netanyahu in court to testify in corruption trial

Israel's Prime Minister Benjamin Netanyahu arrived in court in Tel Aviv on Tuesday to testify for the first time in his corruption case.

Suspect charged with US insurance chief's murder

A 26-year-old man was arrested and charged with murder Monday in the targeted killing of a health insurance executive on the streets of New York, along with other violations.

Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company received a letter from the Staff at Nasdaq Listings Qualifications stating that the Company has regained compliance with Listing Rule 5550(a)(2), which specifies rules regarding a minimum bid price of $1.00.

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd., that the safety review committee recommends commencing dosing of the second cohort in its trial entitled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants." The safety review committee made this recommendation after reviewing safety and pharmacokinetic data from participants in the first cohort.

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End

Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain

World’s largest Psychedelic Church to Close SF Site in Coming Weeks Pastor Cites Harassment from City Planning Department

Zide Door, the psychedelic church garnering national recognition for its devotion to the spiritual power of psilocybin mushrooms, will close its San Francisco location by the end of this year - the victim of a city planning department bent on expelling the institution, Pastor Dave Hodges said Tuesday.Church of Ambrosia, which opened Zide Door April 15, 2023, will continue to serve all 120,000 church members at its founding site in Oakland, he said. The Oakland church showcases an impressive mural and other significant psychedelic art.

Brainy, 'normal guy': the suspect in US insurance CEO's slaying

The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.

Connected, brainy, athletic: the suspect in US insurance CEO's slaying

The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.

Suspect arrested after hunt for US insurance chief's killer

A 26-year-old man was arrested Monday over the targeted killing of a health insurance executive on the streets of New York, with police crediting a McDonald's employee in Pennsylvania who spotted a suspicious-looking customer.

French film director denies child actor abuse in landmark trial

A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 denied the charges Monday as his trial opened in Paris, five years after her allegations fired France's #MeToo movement.

Syria rebel leader discusses 'transfer of power' after Assad's fall

Syria's Islamist rebel leader on Monday began discussions on transferring power, a day after rebels dramatically unseated president Bashar al-Assad following decades of brutal rule.

Man questioned in case of murdered health exec

A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.

Man questioned in case of murdered health exec: US media

A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.

Beaten 'unconscious': police violence sparks outrage in Georgia

When Georgian protester Irakli Pipia started praying with a feeble voice, the policeman beating him drew closer to grasp what he was saying.

China probes Nvidia for 'violating' anti-monopoly law

China on Monday launched an investigation into US chip giant Nvidia for allegedly violating its anti-monopoly laws, a top government agency said, as the two countries race for global chipmaking dominance.

Despair grips Afghan women healthcare students facing ban

For Saja, studying nursing at a healthcare institute in Kabul was her last lifeline to make something of herself after women were banned from universities in Afghanistan two years ago.

French director accused of abusing star Haenel goes on trial

A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 was to go on trial in Paris on Monday, five years after her allegations fired France's #MeToo movement.

Evacuations underway as Philippine volcano erupts

A volcano erupted in the central Philippines on Monday, sending a huge ash column high into the sky as the government ordered the evacuation of surrounding villages.

Trauma and terror of Kenya's kidnapped protesters

The Kenyan parliament was ablaze, protesters running through the streets, police firing into the crowds. Among them was John, who believed the unrest could bring about meaningful political change.

Australian police seek three suspects in 'terrorist' synagogue blaze

Australian police said Monday they are hunting for three suspects over an arson attack on a Melbourne synagogue, designating it a terrorist act.

Australian police seek three suspects in synagogue blaze

Australian police said on Monday they are hunting for three suspects over an arson attack on a Melbourne synagogue, which has been designated as a terrorist act.

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of CTD

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia

Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today it has granted Theramex the exclusive commercialization rights to ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures, for Mexico, Canada, Israel, South Africa, and Russia. Theramex will also have the opportunity to commercialize ELADYNOS® in other agreed upon unpartnered regions. Abaloparatide is marketed in the U.S. by Radius under the tradename TYMLOS®.

CMP Recognized by Manage HR Magazine as a Top Outplacement Services Provider

Career Management Partners (CMP), a trusted leader in career transition services, has been recognized as a top Outplacement services provider by Manage HR Magazine. This award highlights CMP's innovative approach, which blends advanced technology and personalized coaching to deliver exceptional outcomes for organizations and their transitioning employees.

Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable Hematocrit Control at the ASH 2024 Annual Meeting

54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (

Dutch authorities suspect Hague building explosion a criminal act

Dutch authorities said on Sunday they believed an explosion and inferno that caused an apartment block to collapse killing at least five people was a criminal act.

Syria Islamist rebel chief hails 'victory', at landmark Damascus mosque

Syria's rebel leader hailed a "historic" victory Sunday from a landmark Damascus mosque after his Islamist Hayat Tahrir al-Sham group headed a lightning offensive, snatching the capital from government control in less than two weeks.

Notre Dame holds first mass after five-year restoration

Newly restored Notre Dame cathedral held its first mass on Sunday, with Christians celebrating the return of the French capital's most famous place of worship after a historic re-opening ceremony.

Toll from Hague building explosion rises to five

At least five bodies have been pulled from the wreckage of an apartment block in The Hague, authorities said, as recovery efforts stretched into a second day on Sunday.

The China Mail - Boulevard (English)

Featured

Thousands expected as Vespa celebrates 80 years in Rome

Budapest Pride to push for equality after reversed ban

Last news